A Look At Becton Dickinson (BDX) Valuation After Recent Share Price Weakness

robot
Abstract generation in progress

Becton Dickinson (BDX) has experienced a significant share price decline, including a 25% drop over the past 3 months. Despite this, Simply Wall St’s analysis suggests BDX is 20.9% undervalued, with a fair value of $192.31 compared to its current price of $152.14, due to its strong MedTech positioning, stable margins, and anticipated share buybacks. However, potential risks like tariffs and execution challenges with its business separation should be considered.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin